| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |